[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

AFRO-NETS> Kaiser Daily HIV/AIDS Report - Tue, 28 Aug 2001


  • Subject: AFRO-NETS> Kaiser Daily HIV/AIDS Report - Tue, 28 Aug 2001
  • From: Cecilia Snyder <csnyder@ccmc.org>
  • Date: Wed, 29 Aug 2001 20:59:47 -0400 (EDT)




Kaiser Daily HIV/AIDS Report - Tue, 28 Aug 2001
-----------------------------------------------

* South African Children Affected by HIV/AIDS Speak at First National
Children's Meeting
* Inconsistencies Found in Kenyan Blood Safety Procedures; Assessment
Could Serve as Model in Developing Countries
* Princess Diana Memorial Fund Launches $7.2 Million Initiative to
Help Africans Dying of HIV/AIDS
* Triangle Pharmaceuticals Sells Shares to Sustain Operations for Two
More Years


--
South African Children Affected by HIV/AIDS Speak at First National
Children's Meeting

South African children met in Cape Town last Friday for the first na-
tional conference of children with HIV/AIDS or with relatives living
with the virus, the AP/Nando Times reports. The children, ages seven
through 18, spoke about "being shunned by their peers, abandoned by
their families," forced to leave school to care for infected family
members, orphaned by the disease and "even blamed by health care
workers" for becoming infected. South African society, which consid-
ers HIV a "shameful illness," has often "stigmatized" those with the
virus. An estimated 4.7 million South Africans have tested positive
for HIV, and the disease has orphaned 700,000 children in the coun-
try. AIDS activists have "lambasted" the South African government for
promoting an "inconsistent policy" on fighting AIDS and for refusing
to provide antiretroviral drugs through the public health system to
HIV-positive pregnant women with HIV/AIDS. Dr. Nono Simelela, who
heads the South African health department's AIDS program, told the
children last Friday that the government "was doing the best it
could," adding, "It's clear that more resources are going to be
needed. As far as humanly possible, we are responding to these chal-
lenges, (but) the processes are slow" (Cohen, AP/Nando Times, 8/24).


--
Inconsistencies Found in Kenyan Blood Safety Procedures; Assessment
Could Serve as Model in Developing Countries

A 1994 assessment of Kenyan blood safety practices found that HIV-
positive blood was transfused 2% of the time due to inconsistent
screening practices at Kenyan government hospitals, according to a
research summary in the Aug. 25 issue of the Lancet. Researchers from
the CDC collected information and blood samples from 1,290 donor-
recipient pairs for 12 weeks from April to July 1994 at six govern-
ment hospitals in Kenya. The blood samples were screened for HIV us-
ing each hospital's "standard practice[s]" and were then later
screened by a reference laboratory at the CDC in order to make a com-
parison. Overall, HIV was found among 6.4% of the blood donors, with
prevalence varying from 2% to 20% by hospital. Thirty-one of the
1,482 units of blood (2.1%) used in transfusions contained HIV, and
of the 1,290 transfusions that were performed using the screened
blood, 26 contained HIV-positive blood. Blood was not regularly
screened in the hospitals due primarily to a shortage of testing
kits. For four weeks during the study period "no HIV test kits were
available nationwide," so the researchers supplied the hospitals with
kits "with which hospital laboratory personnel were familiar." Data
entry errors were also to blame for some of the disparities between
screenings. Results for 99 blood samples were not found in hospital
log books, but had been written down on the testing laboratory
logsheets. "Inconsistent" refrigeration was also a problem, with
blood being kept in household refrigerators that often had "limited
space" and HIV-positive and HIV-negative blood sometimes being stored
together "without clear labels." Equipment problems such as a period
of no electricity and malfunctions with one hospital's antibody test
reader also compromised the safety of the blood supply. A "lack of
quality-assurance programs" and an inconsistency between what types
of donations hospitals screened was also found, according to the re-
searchers. One hospital did not "routine[ly]" test the blood of in-
fants born to HIV-positive mothers because "hospital personnel as-
sumed that children of HIV-infected mothers were also HIV-infected."
The authors concluded, "Although blood screening removed two-thirds
of infected donations, increased attention to blood safety is needed
to prevent this unacceptable risk of HIV transmission by transfu-
sion."

Developing a Model

Although the risk of contracting HIV from tainted blood donations has
been negligible in most Western nations for years, blood screening
programs have been "difficult to implement and sustain" in developing
countries because of limited resources for donor recruitment and
staff training, improper distribution of the needed testing reagents
and "waning support" from international agencies. Based on their
findings, the CDC team recommended that the government pay "increased
attention to training, supervision, quality assurance, enforced regu-
lation and accountability" to improve blood supply safety. Using
those recommendations, the Kenyan Ministry of Health was able to pro-
cure financial support to purchase and distribute rapid HIV test kits
and develop a national training program to improve laboratory prac-
tices. Funding was also found to recruit volunteer donors and to de-
velop "regional transfusion centers" and a "standardized quality as-
surance program" for the government's hospitals. These "[p]ractical
and feasible interventions could dramatically improve blood safety in
many resource-poor countries," the researchers concluded, adding,
"Given the burden of HIV throughout sub-Saharan African countries, it
is time to bring increased attention and resources to eliminate this
preventable mode of HIV transmission" (Moore et al., Lancet, 8/25).


--
Princess Diana Memorial Fund Launches $7.2 Million Initiative to Help
Africans Dying of HIV/AIDS

The Diana, Princess of Wales Memorial Fund begins a $7.2 million ini-
tiative today to "ease the suffering" of Africans in the final stages
of HIV/AIDS and cancer, the AP/Tampa Tribune reports (AP/Tampa Trib-
une, 8/28). Fund grants will be distributed over five years for hos-
pice programs and training and education programs for policy makers,
medical staff and caregivers. Fund Chair Christopher Spence said,
"For millions of people in this region, the approach of death is
characterized by appalling pain, deprivation and neglect. The fund's
Palliative Care Initiative is essentially a challenge to health pol-
icy makers, donors, practitioners and others who care about the issue
-- to recognize that people who are dying are human and that the
close of life should bring dignity and not diminish their humanity"
(Associated Press, 8/28). In addition to pain relief, the initiative
will fund bereavement projects aimed at helping families cope with
the imminent deaths of relatives, especially children orphaned by
AIDS. One project will encourage South African children to make mem-
ory boxes -- aluminum containers that children paint and then discuss
with their dying parents what "reminders of their parents' love" to
put into the boxes (London Daily Telegraph, 8/28). The launch of the
initiative marks the fourth anniversary of Diana's death and the es-
tablishment of the fund. The fund, which receives donations and prof-
its from the sale of approved memorabilia, has pledged more than
$64.9 million to charities thus far this year (Associated Press,
8/28).

--
Triangle Pharmaceuticals Sells Shares to Sustain Operations for Two
More Years

Triangle Pharmaceuticals Inc., which is developing the experimental
HIV drug known as Coviracil, will raise $75 million to sustain opera-
tions for the next two years through the sale of about 28.3 million
shares of stock at $2.65 per share, the AP/Raleigh News & Observer
reports. Last year, two South African patients participating in a
clinical trial of Coviracil and several other AIDS drugs died of
liver toxicity. Triangle proved that Coviracil did not trigger the
deaths, but the issue forced an FDA review, and the company subse-
quently delayed an application for FDA approval. Earlier this month,
Triangle laid off 85 employees -- about one third of the company's
staff. The firm had accumulated a $375 million deficit by the end of
June and expects annual losses for the next few years (AP/Raleigh
News & Observer, 8/27).

--
The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org,
a free service of The Henry J. Kaiser Family Foundation, by National
Journal Group Inc. c 2001 by National Journal Group Inc. and Kaiser
Family Foundation. All rights reserved.

--
Send mail for the `AFRO-NETS' conference to `<afro-nets@usa.healthnet.org>'.
Mail administrative requests to `<majordomo@usa.healthnet.org>'.
For additional assistance, send mail to: `<owner-afro-nets@usa.healthnet.org>'.